Alpha 2.0
Login Register
» Articles » PMID: 5218042

Metabolic and Therapeutic Effects of Hydroxyurea in Chronic Myeloid Leukemia

Overview
Journal JAMA
Publisher American Medical Association
Specialty General Medicine
Date 1966 Mar 21
PMID 5218042
Citations 9
Authors
B J Kennedy
J W Yarbro
Affiliations
Soon will be listed here.
Citing Articles

Haemolytic anemia in a patient of Chronic myeloid leukemia: an unrecognized side-effect of Hydroxyurea?.

Jamal I, Smita S, Choudhary V Niger Med J. 2025; 65(6):1171-1175.

PMID: 39877498 PMC: 11770668. DOI: 10.60787/nmj.v65i6.576.

Self-assemblies of pluronic micelles in partitioning of anticancer drugs and effectiveness of this system towards target protein.

Prasanthan P, Kishore N RSC Adv. 2022; 11(36):22057-22069.

PMID: 35480822 PMC: 9034178. DOI: 10.1039/d1ra03770f.

Stable-Isotope Dilution HPLC-Electrospray Ionization Tandem Mass Spectrometry Method for Quantifying Hydroxyurea in Dried Blood Samples.

Marahatta A, Megaraj V, McGann P, Ware R, Setchell K Clin Chem. 2016; 62(12):1593-1601.

PMID: 27694393 PMC: 6598440. DOI: 10.1373/clinchem.2016.263715.

Minireview: Prognostic factors and the response to hydroxurea treatment in sickle cell disease.

Wang W Exp Biol Med (Maywood). 2016; 241(7):730-6.

PMID: 27026724 PMC: 4950390. DOI: 10.1177/1535370216642048.

Utility of hydroxyurea in mast cell activation syndrome.

Afrin L Exp Hematol Oncol. 2013; 2(1):28.

PMID: 24192267 PMC: 3851743. DOI: 10.1186/2162-3619-2-28.